Improvement of urodynamic indices by single dose oral tadalafil in men with supra sacral spinal cord injury

Urology Journal

Volumn 7, Issue 4, 2010, Pages 249-253

  Taie, Karim ^a   Moombeini, Hayat ^b   Khazaeli, Dinyar ^b   Firouzabadi, Mohammad Salari Panah ^c  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Department of Urology   (Iran)

Author keywords

Drug therapy; Phosphodiesterase inhibitors; Spinal cord injury; Urodynamic

Indexed keywords

CARBOLINE DERIVATIVE; PHOSPHODIESTERASE V INHIBITOR; TADALAFIL;

ARTICLE; BLADDER; DRUG EFFECT; HUMAN; MALE; MICTURITION DISORDER; PATHOPHYSIOLOGY; PILOT STUDY; SPINAL CORD INJURY; URODYNAMICS;

CARBOLINES; HUMANS; MALE; PHOSPHODIESTERASE 5 INHIBITORS; PILOT PROJECTS; SPINAL CORD INJURIES; URINARY BLADDER; URINATION DISORDERS; URODYNAMICS;

EID: 78650231411     PISSN: 17351308     EISSN: 1735546X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wyndaele M, Wyndaele JJ. Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? Spinal Cord. 2006;44:523-9.
2. Giuliano F, Sanchez-Ramos A, Lochner-Ernst D, et al. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Arch Neurol. 2007;64:1584-92.
3. Giuliano F. Phosphodiesterase type 5 inhibitors improve male lower urinary tract symptoms. Eur Urol. 2008;53:1121-3; discussion 3-4.
4. Del Popolo G, Marzi V, Mondaini N, Lombardi G. Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients. Spinal Cord. 2004;42:643-8.
5. Palea S, Rekik M, Rischmann P, Botto H, Lluel P. Tadalafil exerts an additive effect on alfuzosin-induced relaxation in pre-contracted human isolated prostatic adenoma. Journal of Urology. 2008;179:454.
6. Kohler TS, McVary KT. The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors. Eur Urol. 2009;55:38-48.
7. Oger S, Behr-Roussel D, Gorny D, Lebret T, Validire P, Giuliano F. Sildenafil relaxes human detrusor by cyclic gmp-independent signalling pathways. European Urology Supplements. 2008;7:263.
8. Behr-Roussel D, Oger S, Tinel H, Sandner P, Giuliano F. 768 PDE5 Gene expression and relaxant effects of vardenafil in male and female human and rat detrusor muscle. European Urology-Supplements. 2008;7:263.
9. Linsenmeyer TA, Culkin D. APS recommendations for the urological evaluation of patients with spinal cord injury. J Spinal Cord Med. 1999;22:139-42.
10. Butler MR. Patterns of bladder recovery in spinal injury evaluated by serial urodynamic observations. Urology. 1978;11:308-14.
11. Chou FH, Ho CH, Chir MB, Linsenmeyer TA. Normal ranges of variability for urodynamic studies of neurogenic bladders in spinal cord injury. J Spinal Cord Med. 2006;29:26-31.
12. Gacci M, Del Popolo G, Macchiarella A, et al. Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study. J Urol. 2007;178:2040-3; discussion 4.
13. Tinel H, Stelte-Ludwig B, Hutter J, Sandner P. Preclinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. BJU Int. 2006;98: 1259-63.
14. Beamon CR, Mazar C, Salkini MW, Phull HS, Comiter CV. The effect of sildenafil citrate on bladder outlet obstruction: a mouse model. BJU Int. 2009;104:252-6.
15. Gonzalez RR, Kaplan SA. Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Expert Opin Drug Metab Toxicol. 2006;2:609-17.
16. Roehrborn C. Lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and phosphodiesterase-5 inhibitors. Reviews in Urology. 2004;6:121.
17. Broderick GA, Brock GB, Roehrborn CG, Watts SD, Elion-Mboussa A, Viktrup L. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction. Urology. 2010;75:1452-8.